Bon Natural Life Limited
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Yongwei Hu
- Full Time Employees
- 97
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- Sertus Chambers Grand Cayman Cayman Islands KY1-1104
- IPO Date
- Jun 24, 2021
- CIK
- 0001816815
- Website
- bnlus.com
- Similar Companies
- Business
- Bon Natural Life Limited is engaged in the exploration, production, and distribution of specialized active ingredients derived from natural plant sources, catering to markets both in the People's Republic of China and internationally. The company provides essential components for personal care, including botanical fragrance compounds for various perfume and scent manufacturers. Additionally, it develops natural health supplements such as powdered drink mixes and bioactive food ingredients, which are largely incorporated into food products and nutritional formulas. The firm also features its own branded health solutions, notably in areas like weight management and digestive wellness. Expanding its capabilities, Bon Natural Life recently established an AI-driven research and development division for drug discovery, leading to breakthroughs such as identifying promising weight-managing compounds from tea. These diverse products are predominantly supplied to manufacturer clients within the functional food, personal care, cosmetic, and pharmaceutical industries. Founded in 2006, the company's operational base is located in Xi'an, People's Republic of China.
BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives
Analyzing Sow Good (NASDAQ:SOWG) & Bon Natural Life (NASDAQ:BON)
Head-To-Head Contrast: Bon Natural Life (NASDAQ:BON) vs. Pigeon (OTCMKTS:PGENY)
BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market
BON Partners with Chang'an Pilot to Launch World-Class Joint Laboratory for Natural Ingredient Bio-manufacturing
Foxx Development (NASDAQ:FOXX) & Bon Natural Life (NASDAQ:BON) Head-To-Head Contrast
Bon Natural Life Limited (NASDAQ:BON) Sees Significant Increase in Short Interest
Lifetime Brands (NASDAQ:LCUT) & Bon Natural Life (NASDAQ:BON) Head-To-Head Review
BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan
BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan
BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products
BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform
BON Announces Reciept of Nasdaq Compliance Letter
BON Launches AI-Powered New Drug Research and Development
BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd
BON Announces Nasdaq Compliance
Bon Announces Breakthrough Order for $16 Million Gut-Health Products
Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.
BON Announces Share Repurchase Program for up to US$1.0 Million
BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade